U.S. Personal Products Stock News

NYSE:COLD
NYSE:COLDIndustrial REITs

Does Americold (COLD) Pairing Weak Q4 Results With a New CFO Reset Its Balance Sheet Story?

Americold Realty Trust, Inc. reported fourth-quarter 2025 results showing sales of US$600.68 million and revenue of US$658.45 million, with net loss widening to US$88.34 million and loss per share from continuing operations at US$0.31. Alongside these weaker results, the company introduced a new Chief Financial Officer, Chris Papa, and set out a detailed 2026 plan focused on balance sheet repair, cost reductions, and targeted growth in higher-value cold storage segments. Next, we’ll examine...
NasdaqGS:THRM
NasdaqGS:THRMAuto Components

Gentherm (THRM) Valuation Check After Earnings Miss Record Revenue And New 2026 To 2027 Guidance

Gentherm (THRM) is back in focus after reporting fourth quarter and full year 2025 results that showed much lower net income alongside record revenue, along with new revenue guidance for 2026 and 2027. See our latest analysis for Gentherm. The latest results and 2026 to 2027 revenue guidance came as the share price closed at $32.51, with a 1 day share price return of 4.69% decline and a 1 year total shareholder return of 4.35% decline. This points to pressure on the Gentherm story after...
NYSE:UGI
NYSE:UGIGas Utilities

UGI (UGI) Valuation Check As Q1 Earnings, European Exit And U.S. Expansion Reset Expectations

UGI stock reacts to Q1 earnings and business reshaping UGI (UGI) is in focus after Q1 FY 2026 earnings, a major business reshaping in Europe, senior leadership changes, and expansion into new U.S. states drew fresh attention to the stock. See our latest analysis for UGI. At a share price of US$37.45, UGI has seen a 1 day share price return of 2.19% decline and a softer 7 day and 30 day share price return. However, its 1 year total shareholder return of 17.38% and 5 year total shareholder...
NasdaqGS:STOK
NasdaqGS:STOKBiotechs

Stoke Therapeutics (STOK) Is Up 13.5% After First Patient Dosed In STK-002 OSPREY Trial

Stoke Therapeutics recently reported that it has dosed the first patient in its Phase 1 OSPREY trial of STK-002, an investigational antisense oligonucleotide designed to boost OPA1 protein expression and potentially treat Autosomal Dominant Optic Atrophy, a rare inherited cause of progressive, irreversible vision loss with no approved therapies. This first-in-human study moves Stoke’s TANGO platform into a new ophthalmic indication, offering an early real-world test of whether upregulating...
NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

Amgen’s New UPLIZNA Nod and $4 Billion Bond Sale Might Change The Case For Investing In Amgen (AMGN)

In February 2026, Amgen Inc. issued and sold US$4.00 billion of fixed-rate senior unsecured notes maturing between 2031 and 2056, with coupons ranging from 4.200% to 5.650% and net proceeds of about US$3.96 billion to support its corporate financing needs. This large, multi-tranche bond deal, alongside the recent European Commission approval of UPLIZNA for generalized myasthenia gravis, highlights how Amgen is pairing balance-sheet funding with expansion of its rare autoimmune...
NYSE:BG
NYSE:BGFood

Does Viterra Integration And Surging Revenue Shift The Bull Case For Bunge Global (BG)?

Bunge Global recently reported past quarterly results showing revenue growth of very large year on year, beating analyst expectations while also completing the transformational Viterra combination and advancing major growth projects. Despite missing full-year EPS guidance and gross margin estimates, the company’s integration of Viterra and focus on renewable feedstocks and plant-based ingredients appear central to its evolving business mix. Next, we’ll examine how this strong revenue...
NYSE:GHC
NYSE:GHCConsumer Services

Graham Holdings (GHC) Valuation Check After Recent Share Price Weakness

Graham Holdings (GHC) has been drawing attention after recent share price moves, including a 1 day decline and mixed returns over the past month and past 3 months. These developments are prompting investors to reassess this diversified holding company. See our latest analysis for Graham Holdings. At a share price of US$1,069.64, Graham Holdings has seen pressure in the short term, with a 30 day share price return of an 8.74% decline. Longer term performance, reflected in an 18.24% 1 year...
NYSE:GPN
NYSE:GPNDiversified Financial

Is It Time To Reassess Global Payments (GPN) After Its Recent 16% Weekly Jump?

If you are wondering whether Global Payments is starting to look like value, you are not alone. The stock has attracted fresh attention from investors asking if the current price still reflects its long term potential. After a strong 7 day return of 16.1% to US$79.49, recent performance over 30 days at 5.7% and year to date at 5.2% sits against a much softer picture over longer periods, with 1 year, 3 year and 5 year returns of 22.5%, 27.9% and 58.9% declines respectively. Recent headlines...
NYSE:MCK
NYSE:MCKHealthcare

Should a Probe of McKesson’s Share Issuance and Governance Practices Require Action From McKesson (MCK) Investors?

Faruqi & Faruqi, LLP has begun investigating McKesson’s Board over potential fiduciary breaches tied to the 2013 Stock Plan and its recommendation to issue 30,000,000 additional shares, raising concerns about the impact on existing shareholders. This scrutiny focuses attention on how governance decisions around equity issuance could affect ownership stakes and the company’s long-term capital allocation approach. We’ll now examine how concerns about substantial share issuance and potential...
NasdaqGS:SBAC
NasdaqGS:SBACSpecialized REITs

Is SBA Communications (SBAC) Pricing Look Interesting After Recent Share Price Reset?

If you are wondering whether SBA Communications is attractively priced or still looks expensive at around US$199.64, starting with a clear view of its valuation can help you frame the opportunity and the risks. The stock has been relatively flat over the last week with a 0.6% decline, while the 30 day return sits at 6.7% and the 1 year return at a 4.3% decline. Some investors may see this as a reset after a 19.0% decline over 3 years and a 13.6% decline over 5 years. Recent coverage has...
NYSE:GEL
NYSE:GELOil and Gas

Should Genesis Energy’s Expanded Bond Buyback and New 2034 Debt Require Action From GEL Investors?

Genesis Energy, L.P. recently expanded its previously announced cash tender offer for 7.750% senior notes due 2028, moving from a US$490 million cap to an “any and all” structure, funded by new senior unsecured notes due 2034 and other fixed-income financing completed in February 2026. This combination of a broadened bond buyback and fresh longer-dated debt issuance highlights an assertive approach to reshaping Genesis Energy’s capital structure and managing upcoming maturities. We’ll now...
NasdaqGS:AAPL
NasdaqGS:AAPLTech

Assessing Apple (AAPL) Valuation After Record Q1 2026 Earnings AI Plans And Supply Chain Shifts

Apple (AAPL) is back in focus after record fiscal Q1 2026 results, strong iPhone demand, and growing services revenue, paired with fresh AI product plans and moves to reshore parts of its supply chain. See our latest analysis for Apple. Apple’s recent AI announcements, reshoring efforts and record Q1 results appear to have supported a 7.31% 1 month share price return, even though the year to date share price return is slightly negative and the 5 year total shareholder return of 113.86% points...
NYSE:SPOT
NYSE:SPOTEntertainment

A Look At Spotify Technology’s Valuation After Strong Earnings And Upbeat Guidance

Spotify Technology (NYSE:SPOT) is back in focus after its latest earnings release, where the company reported quarterly and full year results, issued fresh guidance, and updated investors on its ongoing share repurchase activity. See our latest analysis for Spotify Technology. After these earnings and guidance updates, Spotify's 1-day share price return of 4.64% and 30-day share price return of 8.84% sit within a wider trend where the year to date share price return is 18.64%, while the 3...
NasdaqGS:EEFT
NasdaqGS:EEFTDiversified Financial

Is It Time To Reassess Euronet Worldwide (EEFT) After A 30% One-Year Share Price Slump

If you are wondering whether Euronet Worldwide's current share price still reflects its true worth, you are not alone. This article is built to help you assess that question clearly. The stock last closed at US$70.53, with a 3.8% return over the past 7 days, but longer term returns sit at a 4.8% decline year to date and a 30.7% decline over the past year. This may have changed how some investors view its risk and potential. Recent coverage of Euronet Worldwide has focused on its position...
NYSE:PPL
NYSE:PPLElectric Utilities

PPL Equity Units Offering Fuels Grid Investment And Dividend Growth Plans

PPL Corporation (NYSE:PPL) announced a public offering of 20 million equity units. Each equity unit combines a stock purchase contract with an interest in remarketable senior notes. The transaction is structured as a capital markets offering to raise funding for the company. PPL is a regulated utility holding company focused on electricity, an area that continues to attract investor attention because of its link to essential services and long term infrastructure investment. For shareholders...
NYSE:NI
NYSE:NIIntegrated Utilities

NiSource (NI) Valuation Check After Strong 2025 Earnings And Solid Shareholder Returns

Why NiSource’s latest earnings matter for shareholders NiSource (NI) has just released its fourth quarter and full year 2025 results, reporting higher sales, revenue, net income, and earnings per share compared with 2024. This has put fresh attention on the stock’s recent performance. See our latest analysis for NiSource. Despite a small pullback in the latest session, with a 1 day share price return of 0.37%, NiSource’s recent 30 day and year to date share price returns of 6.43% and 9.58%...
NasdaqGS:CHRD
NasdaqGS:CHRDOil and Gas

Is Chord Energy (CHRD) Pricing Look Attractive After Recent Nasdaq Spotlight?

If you are wondering whether Chord Energy's share price still reflects good value or if the opportunity has passed, looking closely at how the market is pricing the business can give you useful clues. The stock recently closed at US$105.25, with returns of 3.2% over the past 7 days, 10.2% over the last 30 days, 11.2% year to date and a 0.3% decline over the last year, which may leave investors debating whether this is renewed enthusiasm or a reassessment of risk. Recent news flow around...
NYSE:CRK
NYSE:CRKOil and Gas

A Look At Comstock Resources (CRK) Valuation After Gas‑Price Driven Share Price Weakness

Comstock Resources (CRK) is back in focus after a sharp 8.86% share price drop over the past week, driven mainly by weaker natural gas prices despite recently reported 2025 earnings and new growth plans. See our latest analysis for Comstock Resources. Beyond the recent week, Comstock Resources has seen its share price weaken more broadly, with a 30 day share price return of 23.04% and a 90 day share price return of 25.86%. Even though the 5 year total shareholder return of 229.92% still...
NasdaqGS:SANA
NasdaqGS:SANABiotechs

Assessing Sana Biotechnology (SANA) Valuation After Recent Share Price Momentum

Sana Biotechnology (SANA) has been drawing attention after a mixed stretch in its share performance, with a small gain over the past week contrasting with a decline over the past month. See our latest analysis for Sana Biotechnology. At the current share price of $4.07, Sana Biotechnology has seen a 5.71% 7 day share price return and a 15.95% 90 day share price return. Its 1 year total shareholder return of 41.32% contrasts with a 5 year total shareholder return loss of 87.76%, suggesting...
NasdaqGS:CALM
NasdaqGS:CALMFood

How Investors May Respond To Cal-Maine Foods (CALM) Board Loss And Prepared Foods Expansion Plan

In February 2026, Cal-Maine Foods reported the passing of long-serving director Jim Poole, whose audit, financial and governance expertise had shaped key board committees for over two decades. At the same time, new institutional interest and a US$36.00 million investment to expand prepared foods capacity highlighted Cal-Maine’s focus on higher-value egg products and product mix evolution. Next, we’ll examine how Cal-Maine’s planned 30%+ prepared foods capacity expansion could influence its...
NYSE:ETSY
NYSE:ETSYMultiline Retail

Etsy Refocuses On Core Marketplace As Tariff Shift Alters Outlook

Etsy agreed to sell Depop to eBay for $1.2b, stepping back from its house of brands approach to focus on its core marketplace. The Supreme Court struck down tariffs that had affected cross border trade, a change that could support Etsy's international operations. These developments arrive as Etsy (NYSE:ETSY) trades around $52.37 and works through mixed share performance in recent years. Etsy, trading at about $52.37, has seen a 14.5% gain over the past week alongside a 13.0% decline over...
NYSE:WTRG
NYSE:WTRGWater Utilities

Assessing Essential Utilities (WTRG) Valuation After Recent Mixed Share Performance

Why Essential Utilities Is On Watch Now Essential Utilities (WTRG) has caught investor attention after a period of mixed share performance, with a small gain over the past month alongside a slight decline over the past 3 months. That backdrop has some investors revisiting the company’s fundamentals, including its regulated water and natural gas businesses and recent financial figures, to decide whether the current pricing fairly reflects its long term prospects. See our latest analysis for...
NasdaqGM:FOLD
NasdaqGM:FOLDBiotechs

Assessing Amicus Therapeutics (FOLD) Valuation After A Strong 3 Month Share Price Rally

Amicus Therapeutics (FOLD) has drawn investor attention after a strong past 3 months, with a total return of about 45% and a 1-year total return above 50%, prompting closer scrutiny of its fundamentals. See our latest analysis for Amicus Therapeutics. The recent move in Amicus Therapeutics' share price to $14.36 sits on top of a strong 90 day share price return of about 45%, while the 1 year total shareholder return of roughly 54% points to momentum that has been building rather than...
NYSE:DVA
NYSE:DVAHealthcare

Will DaVita’s (DVA) US$5.6 Billion Buybacks and Tech Push Change Its Capital Allocation Narrative

Earlier in February 2026, DaVita Inc. completed two major share repurchase tranches under its 2020 and 2024 buyback programs, retiring millions of shares for a combined outlay of more than US$5.63 billion. This large-scale reduction in share count, alongside CEO Javier Rodriguez’s upcoming appearance at the ViVE 2026 conference in Los Angeles, highlights how DaVita is pairing capital returns with a focus on its long-term care and technology agenda. We’ll now examine how the completion of...